Stephen Worland - EFFECTOR Therapeutics President CEO
CEO
Stephen Worland is President CEO of EFFECTOR Therapeutics
| Age | 66 |
| Phone | 858 925 8215 |
| Web | https://effector.com |
Stephen Worland Latest Insider Activity
Tracking and analyzing the buying and selling activities of Stephen Worland against EFFECTOR Therapeutics pink sheet is an integral part of due diligence when investing in EFFECTOR Therapeutics. Stephen Worland insider activity provides valuable insight into whether EFFECTOR Therapeutics is net buyers or sellers over its current business cycle. Note, EFFECTOR Therapeutics insiders must abide by specific rules, including filing SEC forms every time they buy or sell EFFECTOR Therapeutics'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Stephen Worland over six months ago Acquisition by Stephen Worland of 1806 shares of Effector Therapeutics at 1.683 subject to Rule 16b-3 | ||
Stephen Worland over six months ago Disposition of 33799 shares by Stephen Worland of EFFECTOR Therapeutics at 0.52 subject to Rule 16b-3 | ||
Stephen Worland over six months ago Acquisition by Stephen Worland of 33799 shares of EFFECTOR Therapeutics at 0.52 subject to Rule 16b-3 | ||
Stephen Worland over a year ago Acquisition by Stephen Worland of 80000 shares of Effector Therapeutics at 11.32 subject to Rule 16b-3 |
EFFECTOR Therapeutics Management Efficiency
The company has return on total asset (ROA) of (0.8333) % which means that it has lost $0.8333 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (9.4656) %, meaning that it generated substantial loss on money invested by shareholders. EFFECTOR Therapeutics' management efficiency ratios could be used to measure how well EFFECTOR Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 1 records | CEO Age | ||
| Stephen Esq | NRx Pharmaceuticals | 63 | |
Management Performance
| Return On Equity | -9.47 | |||
| Return On Asset | -0.83 |
EFFECTOR Therapeutics Leadership Team
Elected by the shareholders, the EFFECTOR Therapeutics' board of directors comprises two types of representatives: EFFECTOR Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of EFFECTOR. The board's role is to monitor EFFECTOR Therapeutics' management team and ensure that shareholders' interests are well served. EFFECTOR Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, EFFECTOR Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Siegfried Reich, CoFounder Advisor | ||
| Mayank MD, Chief Officer | ||
| Michael MBA, Chief Officer | ||
| Alana MBA, Chief Officer | ||
| Premal MD, Chief Officer | ||
| Davide Ruggero, CoFounder Board | ||
| Douglas MD, Chief Officer | ||
| Stephen Worland, President CEO | ||
| Kevan Shokat, CoFounder Board |
EFFECTOR Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is EFFECTOR Therapeutics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -9.47 | |||
| Return On Asset | -0.83 | |||
| Number Of Shares Shorted | 18.44 K | |||
| EBITDA | (33.73 M) | |||
| Net Income | (35.81 M) | |||
| Total Debt | 19.45 M | |||
| Book Value Per Share | 0.21 X | |||
| Cash Flow From Operations | (29.55 M) | |||
| Earnings Per Share | (0.91) X | |||
| Number Of Employees | 14 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Consideration for investing in EFFECTOR Pink Sheet
If you are still planning to invest in EFFECTOR Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the EFFECTOR Therapeutics' history and understand the potential risks before investing.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |